Statins Versus Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors- Are We Doing Better? A Systematic Review on Treatment Disparity

Coronary artery disease (CAD) is a significant contributor to mortality in America. A common risk factor of CAD is hyperlipidemia. Treatment guidelines of hyperlipidemia are well established. Statins are the cornerstone of treating hyperlipidemia. New medications such as proprotein convertase subtil...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cureus
Main Authors: Singh, Chetana, Valero, Danel J, Nisar, Javariya, Trujillo Ramirez, Jose I, Kothari, Karisma K, Isola, Sasank, San Hernandez, Aleyda M, Gordon, Domonick K
Formato: Artigo
Idioma:Inglês
Publicado: Cureus 2020
Assuntos:
Cardiology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7667606/
https://ncbi.nlm.nih.gov/pubmed/33209524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.10965
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares